Astera Labs (NASDAQ:ALAB) CEO Sells $11,758,359.51 in Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Astera Labs Trading Up 2.3%

Astera Labs stock traded up $3.04 during trading hours on Thursday, reaching $132.62. 2,894,530 shares of the company were exchanged, compared to its average volume of 5,941,660. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a 50-day moving average of $160.78 and a 200 day moving average of $174.12. The firm has a market cap of $22.40 billion, a price-to-earnings ratio of 108.70, a PEG ratio of 2.55 and a beta of 1.50.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. Astera Labs’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ALAB shares. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Raymond James Financial began coverage on Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating on the stock. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, JPMorgan Chase & Co. upped their target price on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $192.89.

Read Our Latest Stock Report on Astera Labs

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently made changes to their positions in the business. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank boosted its holdings in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new position in shares of Astera Labs during the 4th quarter worth about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs in the 4th quarter valued at about $33,000. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.